Towards Precision Cancer Therapy – From Biomarker Identification to Companion Diagnostic Assay Development
Xtalks Webinar Presentation
|SPEAKER:||Anguraj Sadanandam, PhD, Team Leader (Tenured Career Faculty/Associate Professor), Institute of Cancer Research (ICR)|
Sep 04, 2019
Anguraj Sadanandam, Ph.D. and colleagues at the Institute of Cancer Research have used NanoString® nCounter® technology to classify different gastrointestinal tumor types including colorectal cancer using gene signatures associated with cell-of-origin/phenotype, therapeutic response, and prognosis. Dr. Sadanandam will discuss the process of biomarker and companion diagnostic development including machine learning approaches in different gastrointestinal cancers and their translational relevance.